Home › Trial NCT05158608
Comparison of PT-Cy at a Dose of 25 mg/kg/Day and PT-Cy at a Dose of 50 mg/kg/Day in GVHD Prophylaxis
- Trial IDNCT05158608
- StatusUnknown
- PhasePhase 3
- Study typeInterventional
- SponsorNational Research Center for Hematology, Russia
- Enrollment100
- Start date2022-01-01
- ConditionsGraft Versus Host Disease · Hematologic Malignancy · Cyclophosphamide Adverse Reaction
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.